Vertex Pharmaceuticals (NASDAQ:VRTX), a leading biotechnology company with a market capitalization of $113.7 billion, is navigating a critical juncture as it seeks to expand its therapeutic reach and ...

Having lived with disabling chronic pain for 32 years, one reader discovered a lesser known treatment that has transformed ...

Novartis AG (NYSE:NVS), a global healthcare company valued at over $206 billion, has undergone significant transformation in recent years, focusing its efforts on becoming a pure-play pharmaceutical ...

The skills you already have, such as building rapport, sitting with difficult emotions, and supporting the integration of ...

Weill Cornell Medicine investigators have identified in a preclinical model a specific brain circuit whose inhibition appears ...

SAB-142 was generally well-tolerated among healthy volunteers; data from Phase 1 trial confirms SAB-142 does not cause serum sickness or ...

The popular wand that promotes collagen production and offers other anti-aging skin benefits is miraculously under $100 at ...

Harm reduction isn't just a strategy; it's an act of compassion that rewrites the script of addiction treatment, offering a ...

Australian Open champion Madison Keys credits therapy with helping her understand herself, and that helped her become a ...

Kidney function decline (KFD) in patients undergoing aortic vascular surgical procedures remains a significant global health ...

Two new meta-analyses make a case for individualistic approaches to puberty blockers and hormone treatments, driven by ...

Columnist Ben Hofmeister reflects on his journey treating depression and what he wishes he knew earlier about MS and mental health.